Captor Therapeutics S.A. (CTX) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.346x

Based on the latest financial reports, Captor Therapeutics S.A. (CTX) has a cash flow conversion efficiency ratio of -0.346x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-11.51 Million ≈ $-3.17 Million USD) by net assets (zł33.27 Million ≈ $9.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CTX defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Captor Therapeutics S.A. - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Captor Therapeutics S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Captor Therapeutics S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Captor Therapeutics S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Roots Corp TO:ROOT	0.300x
Kc Cottrell KO:119650	-0.341x
ABOV Semiconductor Co. Ltd KQ:102120	-0.013x
GOLCONDA GOLD LTD F:Y87	0.075x
Cantor Equity Partners, Inc. Class A Ordinary Shares NASDAQ:CEP	N/A
Chien Shing Harbour Service Co Ltd TW:8367	0.042x
Lan Fa Textile Co Ltd TW:1459	0.027x
Eco World International Bhd KLSE:5283	-0.009x

Annual Cash Flow Conversion Efficiency for Captor Therapeutics S.A. (2017–2024)

The table below shows the annual cash flow conversion efficiency of Captor Therapeutics S.A. from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Captor Therapeutics S.A. stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł64.47 Million ≈ $17.74 Million	zł-31.88 Million ≈ $-8.77 Million	-0.494x	+34.44%
2023-12-31	zł69.22 Million ≈ $19.05 Million	zł-52.20 Million ≈ $-14.37 Million	-0.754x	-216.56%
2022-12-31	zł96.32 Million ≈ $26.51 Million	zł-22.95 Million ≈ $-6.32 Million	-0.238x	-3.92%
2021-12-31	zł124.20 Million ≈ $34.18 Million	zł-28.47 Million ≈ $-7.84 Million	-0.229x	-138.68%
2020-12-31	zł-1.00 Million ≈ $-276.32K	zł-595.00K ≈ $-163.75K	0.593x	-42.31%
2019-12-31	zł4.28 Million ≈ $1.18 Million	zł4.39 Million ≈ $1.21 Million	1.027x	+265.41%
2018-12-31	zł3.43 Million ≈ $944.26K	zł-2.13 Million ≈ $-586.48K	-0.621x	-104.27%
2017-12-31	zł144.00K ≈ $39.63K	zł2.10 Million ≈ $577.12K	14.563x	--

About Captor Therapeutics S.A.

WAR:CTX Poland Biotechnology

Market Cap

$117.65 Million

zł427.48 Million PLN

Market Cap Rank

#18669 Global

#142 in Poland

Share Price

zł77.60

Change (1 day)

-0.51%

52-Week Range

zł31.90 - zł87.60

All Time High

zł202.00